160 Participants Needed

Sleep Chronobundle for Circadian Rhythm Disorder

(ReAlign-ICU Trial)

Recruiting at 1 trial location
MP
Overseen ByMelissa P Knauert, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new approach to help ICU patients improve sleep and overall health by aligning their internal clocks with natural rhythms. The treatment, known as a "chronobundle," involves managing light exposure, meal timing, exercise, and sleep schedules. The researchers aim to determine if better alignment of the body's natural rhythms can enhance sleep quality and metabolic health in critically ill patients. Suitable participants include those in the ICU needing machine support for breathing or circulation. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve ICU care.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What prior data suggests that this sleep chronobundle is safe for patients with circadian rhythm disorder?

Research shows that treatments like the "sleep chronobundle," which aim to improve sleep and synchronize body clocks, are generally safe. The chronobundle includes bright light during the day, scheduled meals, exercise, and sleep support. It is designed to help people in the ICU, where sleep and body clock disruptions are common.

Studies on similar treatments have shown they are well-tolerated. For example, using light therapy and managing sleep schedules has not caused serious side effects. Evidence also indicates that melatonin, often used in these treatments, does not lead to major negative reactions.

Overall, existing research considers these strategies safe. Participants can expect few, if any, negative side effects, making it a promising option for improving sleep and health in the ICU.12345

Why are researchers excited about this trial?

Researchers are excited about the Sleep Chronobundle for Circadian Rhythm Disorder because it takes a holistic approach by combining bright daytime light, time-restricted feeding, enhanced exercise, and overnight sleep promotion. This method stands out because it doesn't just focus on one aspect of treatment but addresses multiple lifestyle factors that influence circadian rhythms. Unlike standard treatments that might rely on medication to adjust sleep patterns, the Chronobundle emphasizes natural interventions that could offer a more sustainable and side-effect-free way to reset the body's internal clock. This multifaceted approach has the potential to significantly improve patients' circadian rhythms and overall health.

What evidence suggests that this trial's treatments could be effective for circadian rhythm disorder?

This trial will compare the effects of a comprehensive treatment approach called the Chronobundle with usual ICU care. Research has shown that aligning the body's internal clock can enhance sleep and improve food processing. Studies have found that bright light therapy, combined with planned meal times and exercise, can reset the natural sleep-wake cycle. Specifically, using bright light in the morning and eating at set times can improve sleep patterns. These methods have been shown to facilitate falling asleep, enhance sleep quality, and reduce symptoms of sleep disorders. Such strategies may aid recovery in healthcare settings, potentially benefiting ICU patients with sleep difficulties.12678

Who Is on the Research Team?

MP

Melissa P Knauert, MD, PhD

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for adult patients recently admitted to the MICU who are intubated and not expected to be extubated within 24 hours. It's not suitable for those with severe brain injuries, circadian disorders, recent shift work, homelessness, high risk of aspiration or hypoglycemia issues.

Inclusion Criteria

I am on a breathing machine and haven't passed a breathing test.
Patients admitted to the intensive care unit within 24 hours of 9:00 on the day of enrollment.

Exclusion Criteria

I am at high risk for low blood sugar episodes.
You have a high chance of having existing sleep pattern issues due to severe brain injury, circadian disorder, recent shift work, homelessness, being in jail, or living in an institution.
You are not expected to produce more than 250 milliliters of urine in a day.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive the sleep chronobundle intervention, including bright daytime light, time-restricted feeding, increased mobility, and overnight sleep promotion

72 hours
Continuous monitoring in ICU

Follow-up

Participants are monitored for safety and effectiveness after treatment, including metrics such as sleep and glucose metabolism

14 days
Daily assessments in ICU

Long-term Follow-up

Participants are monitored for outcomes such as ventilator-free days, time to hospital discharge, and mortality

30 days

What Are the Treatments Tested in This Trial?

Interventions

  • Chronobundle - Feeding
  • Chronobundle - Light
  • Chronobundle - Mobility
  • Chronobundle - Sleep
Trial Overview The study tests a 'chronobundle' approach in ICU patients to align sleep and eating patterns with natural body clock rhythms. The goal is to see if this improves sleep quality and metabolic function by promoting normal circadian alignment.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: ChronobundleExperimental Treatment4 Interventions
Group II: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

A comprehensive review of circadian rhythm sleep disorders (CRSDs) highlights effective evaluation methods, including physiological assessments like core body temperature and melatonin timing, as well as behavioral assessments such as sleep logs and actigraphy.
Treatment options for CRSDs include prescribed sleep schedules, circadian phase shifting, and medications, but the success of these interventions varies, indicating a need for further research with subjects meeting current diagnostic criteria.
Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.Sack, RL., Auckley, D., Auger, RR., et al.[2022]
Primary circadian rhythm sleep disorder (CRSD) cases were diagnosed at a younger age and showed a better response to treatments like vitamin B12 and bright light therapy compared to secondary CRSD cases, which often had underlying psychiatric or medical conditions.
The majority of primary CRSD cases were delayed sleep phase syndrome (83.7%), while secondary CRSD cases had a more varied pattern, indicating different underlying mechanisms and treatment responses between the two types of disorders.
Clinical features of circadian rhythm sleep disorders in outpatients.Yamadera, W., Sasaki, M., Itoh, H., et al.[2015]
A study using blue light pulses delivered through a sleep mask showed significant melatonin suppression, indicating its potential effectiveness in regulating circadian rhythms in older adults.
In a field study, these blue light pulses were found to effectively delay circadian phase in older adults, suggesting that this method of light therapy could be a practical and compliant treatment for sleep disorders at home.
Pulsing blue light through closed eyelids: effects on acute melatonin suppression and phase shifting of dim light melatonin onset.Figueiro, MG., Plitnick, B., Rea, MS.[2022]

Citations

Sleep Chronobundle for Circadian Rhythm DisorderThis trial tests a 'sleep chronobundle' to help ICU patients by improving their sleep and aligning their body clocks.
Treatment of Circadian Rhythm Sleep–Wake Disorders - PMCA recent study showed that 0.5 mg of melatonin combined with behavioral wake-up scheduling can advance sleep onset time, improve sleep quality, and reduce sleep ...
NCT03682185 | The Healthy Patterns Sleep StudyThe Healthy Patterns Study intervention is a home-based activity intervention designed to improve symptoms of circadian rhythm disorders (CRD) and quality ...
Enhancing circadian rhythms—the circadian MEGA bundle as ...A MEGA bundle consisting of intense light therapy each morning, cyclic nutrition support, timed physical therapy, nighttime melatonin administration.
American Journal of Respiratory and Critical Care MedicineSleep and circadian rhythms are believed to play an important role in recovery from injury and illness. Sleep quality and quantity are linked to mortality in ...
Reestablishing Sleep and Circadian Alignment in Medical ...This project will test the ability of a sleep chronobundle (i.e., sleep promotion and circadian treatment bundle) to normalize circadian ...
Project Details - NIH RePORTERThis project will test the ability of a sleep chronobundle (i.e., sleep promotion and circadian treatment bundle) to normalize circadian alignment and ...
Sleep Bundle for Improving Sleep in ICU PatientsThe project " sleep bundle " aims at improving the sleep of the patients by the implementation of a multimodal intervention that consists in a ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security